Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Maung

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 28, 2004
Doxercalciferol safely suppresses PTH levels in patients with secondary hyperparathyroidism associated with chronic kidney disease stages 3 and 4Jack W Coburn, Hla M Maung, Logan Elangovan, et al.
Public Health Action|April 10, 2019
Tuberculosis-diabetes screening: how well are we doing? A mixed-methods study from North IndiaA Majumdar, E Wilkinson, P K Rinu, et al.
Science Advances|February 26, 2020
On the glacial-interglacial variability of the Asian monsoon in speleothem δ<sup>18</sup>O recordsG Liu, X Li, H-W Chiang, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 8, 2000
Intermittent doxercalciferol (1alpha-hydroxyvitamin D(2)) therapy for secondary hyperparathyroidismJ M Frazão, L Elangovan, H M Maung, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 3, 2001
Efficacy and side effects of intermittent intravenous and oral doxercalciferol (1alpha-hydroxyvitamin D(2)) in dialysis patients with secondary hyperparathyroidism: a sequential comparisonH M Maung, L Elangovan, J M Frazão, et al.
Life Sciences in Space Research|August 19, 2019
Advances in space radiation physics and transport at NASAJohn W Norbury, Tony C Slaba, Sukesh Aghara, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 28, 2004
Doxercalciferol safely suppresses PTH levels in patients with secondary hyperparathyroidism associated with chronic kidney disease stages 3 and 4Jack W Coburn, Hla M Maung, Logan Elangovan, et al.
Public Health Action|April 10, 2019
Tuberculosis-diabetes screening: how well are we doing? A mixed-methods study from North IndiaA Majumdar, E Wilkinson, P K Rinu, et al.
Science Advances|February 26, 2020
On the glacial-interglacial variability of the Asian monsoon in speleothem δ<sup>18</sup>O recordsG Liu, X Li, H-W Chiang, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 8, 2000
Intermittent doxercalciferol (1alpha-hydroxyvitamin D(2)) therapy for secondary hyperparathyroidismJ M Frazão, L Elangovan, H M Maung, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 3, 2001
Efficacy and side effects of intermittent intravenous and oral doxercalciferol (1alpha-hydroxyvitamin D(2)) in dialysis patients with secondary hyperparathyroidism: a sequential comparisonH M Maung, L Elangovan, J M Frazão, et al.
Life Sciences in Space Research|August 19, 2019
Advances in space radiation physics and transport at NASAJohn W Norbury, Tony C Slaba, Sukesh Aghara, et al.
Pageof 3